Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $935.03 | 58 | 92.7% |
| Education | $74.07 | 3 | 7.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $139.98 | 10 | $0 (2024) |
| ABBVIE INC. | $131.00 | 6 | $0 (2024) |
| Lilly USA, LLC | $98.51 | 6 | $0 (2023) |
| Allergan, Inc. | $95.75 | 5 | $0 (2020) |
| Astellas Pharma US Inc | $85.25 | 4 | $0 (2017) |
| Novo Nordisk Inc | $73.06 | 5 | $0 (2023) |
| PFIZER INC. | $71.87 | 6 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $44.92 | 3 | $0 (2022) |
| Exact Sciences Corporation | $40.14 | 2 | $0 (2023) |
| Ironshore Pharmaceuticals Inc. | $39.18 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.56 | 4 | ABBVIE INC. ($47.13) |
| 2023 | $338.41 | 18 | AbbVie Inc. ($83.87) |
| 2022 | $103.52 | 7 | Novo Nordisk Inc ($41.57) |
| 2021 | $119.41 | 9 | AstraZeneca Pharmaceuticals LP ($54.35) |
| 2020 | $66.33 | 4 | Allergan, Inc. ($53.53) |
| 2019 | $74.76 | 6 | PFIZER INC. ($49.95) |
| 2018 | $110.23 | 6 | AstraZeneca Pharmaceuticals LP ($45.09) |
| 2017 | $120.88 | 7 | Astellas Pharma US Inc ($85.25) |
All Payment Transactions
61 individual payment records from CMS Open Payments — Page 2 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: Diabetes | ||||||
| 04/11/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Diabetes | ||||||
| 03/08/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Diabetes | ||||||
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/29/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/25/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Respiratory | ||||||
| 05/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2021 | PFIZER INC. | PREMARIN (Drug), COLOGUARD DNA CAPTURE REAGENTS, REYVOW | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: WOMENS HEALTH | ||||||
| 05/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/05/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $12.69 | General |
| Category: Cardiovascular | ||||||
| 04/14/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2021 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Genetic Disease | ||||||
| 11/02/2020 | Allergan, Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Respiratory | ||||||
| 10/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2019 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/09/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 04/25/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/09/2019 | PFIZER INC. | LYRICA (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 03/06/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 02/19/2019 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2018 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Endocrinology | ||||||
| 11/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 59 | $963.00 | $415.28 |
| 2022 | 2 | 61 | 87 | $1,435 | $672.52 |
| 2021 | 5 | 141 | 263 | $21,760 | $7,519 |
| 2020 | 1 | 36 | 42 | $714.00 | $405.73 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 39 | $663.00 | $371.28 | 56.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 18 | 20 | $300.00 | $44.00 | 14.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 42 | 65 | $1,105 | $623.74 | 56.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 19 | 22 | $330.00 | $48.78 | 14.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 36 | 100 | $10,000 | $3,391 | 33.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 30 | 50 | $7,500 | $2,657 | 35.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 11 | 15 | $2,670 | $803.16 | 30.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 40 | 60 | $1,020 | $582.60 | 57.1% |
| 81003 | Automated urinalysis test | Office | 2021 | 24 | 38 | $570.00 | $85.50 | 15.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 36 | 42 | $714.00 | $405.73 | 56.8% |
About Dr. Jequita Snyder, D.O
Dr. Jequita Snyder, D.O is a Family Medicine healthcare provider based in Miami, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/06/2007. The National Provider Identifier (NPI) number assigned to this provider is 1255511309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jequita Snyder, D.O has received a total of $1,009 in payments from pharmaceutical and medical device companies, with $75.56 received in 2024. These payments were reported across 61 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($935.03).
As a Medicare-enrolled provider, Snyder has provided services to 281 Medicare beneficiaries, totaling 451 services with total Medicare billing of $9,012. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Miami, OK
- Active Since 11/06/2007
- Last Updated 07/09/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1255511309
Products in Payments
- VRAYLAR (Drug) $92.25
- Myrbetriq (Drug) $85.25
- MAVYRET (Drug) $73.07
- JARDIANCE (Drug) $66.82
- FARXIGA (Drug) $54.86
- UBRELVY (Drug) $49.20
- SYMBICORT (Drug) $45.09
- Rybelsus (Drug) $42.53
- Cologuard Collection Kit (Device) $40.14
- JORNAY PM (Drug) $39.18
- TRELEGY ELLIPTA (Drug) $35.72
- Ozempic (Drug) $30.53
- XARELTO (Drug) $28.18
- XIFAXAN (Drug) $26.09
- CHANTIX (Drug) $25.70
- LYRICA (Drug) $24.25
- Prolia (Biological) $21.06
- WAKIX (Drug) $19.81
- UZEDY (Drug) $18.42
- TRULICITY (Drug) $17.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Miami
Keila Hoover, M.d, M.D
Family Medicine — Payments: $1.1M
Dr. Yamirka Duardo-Guerra, M.d, M.D
Family Medicine — Payments: $1.0M
Ramon Leon, Md, MD
Family Medicine — Payments: $179,798
Mirel Sanchez, M.d, M.D
Family Medicine — Payments: $165,828
Gilberto Seco, Md, MD
Family Medicine — Payments: $127,612
Dr. Clifford Kinder, Md, MD
Family Medicine — Payments: $121,261